First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19

TPE carries a category 3 recommendation for sepsis with multiple organ failure in the 2019 American Society for Apheresis guidelines [10], stating decision-making should be individualized. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing...

Full description

Saved in:
Bibliographic Details
Published in:Critical care (London, England) England), 2020-06, Vol.24 (1), p.363-363, Article 363
Main Authors: Stahl, Klaus, Bode, Christian, David, Sascha
Format: Article
Language:English
Subjects:
Betacoronavirus
Coronavirus
Coronavirus Infections
Coronaviruses
COVID-19
Critical care
Humans
Infections
Letter
Multiple organ dysfunction syndrome
Pandemics
Plasma
Plasma Exchange
Pneumonia, Viral
SARS-CoV-2
Sepsis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:TPE carries a category 3 recommendation for sepsis with multiple organ failure in the 2019 American Society for Apheresis guidelines [10], stating decision-making should be individualized. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the writing committee of the American Society for Apheresis: the eight special issue.
ISSN:1364-8535
1466-609X
1364-8535
1366-609X
DOI:10.1186/s13054-020-03070-7